AU2002365902A1 - Complement mediated assays for in vivo and in vitro methods - Google Patents

Complement mediated assays for in vivo and in vitro methods

Info

Publication number: AU2002365902A1
Authority: AU; Australia
Prior art keywords: vivo; vitro methods; complement mediated; mediated assays; assays
Prior art date: 2001-05-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002365902A

Inventor

Elliot R. Ramberg

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cygene Inc

Original Assignee

Cygene Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-22

Filing date

2002-05-22

Publication date

2003-09-02

2002-05-22 Application filed by Cygene Inc filed Critical Cygene Inc

2003-09-02 Publication of AU2002365902A1 publication Critical patent/AU2002365902A1/en

Status Abandoned legal-status Critical Current

Links

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Cell Biology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Virology (AREA)
Oncology (AREA)
Developmental Biology & Embryology (AREA)
Rheumatology (AREA)
Rehabilitation Therapy (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Hospice & Palliative Care (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2002365902A 2001-05-22 2002-05-22 Complement mediated assays for in vivo and in vitro methods Abandoned AU2002365902A1 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US29261601P	2001-05-22	2001-05-22
US60/292,616		2001-05-22
US29732101P	2001-06-11	2001-06-11
US60/297,321		2001-06-11
US32402901P	2001-09-21	2001-09-21
US60/324,029		2001-09-21
PCT/US2002/016302 WO2003063763A2 (en)	2001-05-22	2002-05-22	Complement mediated assays for in vivo and in vitro methods

Publications (1)

Publication Number	Publication Date
AU2002365902A1 true AU2002365902A1 (en)	2003-09-02

Family

ID=27670579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002365902A Abandoned AU2002365902A1 (en)	2001-05-22	2002-05-22	Complement mediated assays for in vivo and in vitro methods

Country Status (5)

Country	Link
EP (1)	EP1506314A4 (en)
JP (1)	JP2005516198A (en)
AU (1)	AU2002365902A1 (en)
CA (1)	CA2447892A1 (en)
WO (1)	WO2003063763A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001056456A2 (en) *	2000-02-02	2001-08-09	Cygene, Inc.	Methods and compositions for detection of disease

2002
- 2002-05-22 AU AU2002365902A patent/AU2002365902A1/en not_active Abandoned
- 2002-05-22 WO PCT/US2002/016302 patent/WO2003063763A2/en active Application Filing
- 2002-05-22 JP JP2003563459A patent/JP2005516198A/en active Pending
- 2002-05-22 EP EP02806678A patent/EP1506314A4/en not_active Withdrawn
- 2002-05-22 CA CA002447892A patent/CA2447892A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2447892A1 (en)	2003-08-07
WO2003063763A3 (en)	2004-12-09
EP1506314A2 (en)	2005-02-16
JP2005516198A (en)	2005-06-02
EP1506314A4 (en)	2005-08-24
WO2003063763A2 (en)	2003-08-07

Similar Documents

Publication	Publication Date	Title
AU2003264746A1 (en)	2004-04-30	Single-molecule in vitro evolution
AU2002322211A1 (en)	2003-01-29	Methods and compisitions for activation human t cells in vitro
AU2002360670A1 (en)	2003-07-09	Method and related composition employing nanostructures
IL165804A0 (en)	2006-01-15	In vitro fertilisation
AU2001230949A1 (en)	2002-03-26	Fluorescent red composition and articles made therefrom
AU2002318482A1 (en)	2003-01-21	Quantitative in vitro bone induction assay
AU2002346446A1 (en)	2003-06-10	Methods and compositions in checkpoint signaling
AU2002953238A0 (en)	2003-01-02	In vitro immunization
AU2002306461A1 (en)	2002-10-15	In vivo delivery methods and compositions
AU2002301358A1 (en)	2003-06-12	Improvements in Transmissometers
AU2002301354A1 (en)	2003-06-12	Improvements in Transmissometers
AU2002341828A1 (en)	2003-04-01	Enhanced proteins and methods for their use
AU2002365902A1 (en)	2003-09-02	Complement mediated assays for in vivo and in vitro methods
AU2003282241A1 (en)	2004-06-15	Antibodies for in vitro use
AU2002342944A1 (en)	2003-06-17	Fiberboards and processes for the preparation thereof
AU2002364783A1 (en)	2003-06-10	Purified polypeptides involved in general metabolism
AU2002219190A1 (en)	2002-07-16	Method for determining skin ageing in vitro
AU2003290237A1 (en)	2004-06-30	Ceramic articles and their manufacture
AU2002238794A1 (en)	2002-06-03	Methods and compositions involved in groucho-mediated differentiation
AU2002329977A1 (en)	2003-03-10	In vitro protein translation microarray device
AU4231000A (en)	2000-11-14	In vitro ribosome evolution
AU2002241757A1 (en)	2002-06-11	High strength alloys and methods for making same
AU2002317005A1 (en)	2003-03-03	Gamma-secretase in vitro screening assay
AU2002212654A1 (en)	2003-05-06	In vitro micro-organs, and uses related thereto
AUPQ961200A0 (en)	2000-09-14	Homogenous in vitro diagnostic assays

Legal Events

Date	Code	Title	Description
2004-03-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase